# Anti-inflammatories and Adolescent Schizophrenia

> **NCT04020588** · PHASE4 · UNKNOWN · sponsor: **Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico** · enrollment: 90 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Celecoxib 200mg
- **DRUG:** Placebo oral capsule
- **DRUG:** Minocycline 100mg

## Key facts

- **NCT ID:** NCT04020588
- **Lead sponsor:** Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-25
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04020588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04020588, "Anti-inflammatories and Adolescent Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04020588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*